Caribou Biosciences (CRBU) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CRBU Caribou Biosciences

Watchlist

1.895
+0.005+0.26%

Trading Oct 9 11:21 ET

171.24MMarket Cap-1435P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Q3 Pharma and Biotech Layoffs in Charts: More Than 1000 Each in July and August
Seeking AlphaOct 4 14:02 ET
Caribou Biosciences to Present Preclinical Data Supporting Development of CB-010 for Lupus at the American College of Rheumatology Convergence 2024
Yahoo FinanceSep 25 09:00 ET
With 60% Ownership, Caribou Biosciences, Inc. (NASDAQ:CRBU) Boasts of Strong Institutional Backing
Yahoo FinanceSep 18 07:34 ET
Vir Biotechnology Names Jason O'Byrne Finance Chief
MT NewswiresSep 10 08:55 ET
Truist Financial Initiates Caribou Biosciences(CRBU.US) With Buy Rating
Moomoo NewsSep 4 07:31 ET · Ratings
Caribou Biosciences Announces CFO Resignation and Succession Plan
TipRanksSep 3 16:30 ET

Comments

Stock_Drift

Sep 25 08:16

$Caribou Biosciences (CRBU.US)$

FattyChick

Sep 13 12:24

Next 3 stocks keeping an eye on.

$Caribou Biosciences (CRBU.US)$
$Gossamer Bio (GOSS.US)$
$Archer Aviation (ACHR.US)$
Gonna add a position for each again.

Trytosaveabit

Sep 3 07:01

News

$Caribou Biosciences (CRBU.US)$ Reuters· just
Caribou Biosciences Announces the FDA Has Granted Fast Track Designations to CB-010 in Refractory Sle and to CB-012 in Relapsed or Refractory Aml

Jaguar8

Jun 2 20:24

NEWS

$Caribou Biosciences (CRBU.US)$
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Caribou Biosciences presented promising clinical data from its CB-010 ANTLER Phase 1 trial at the 2024 ASCO Annual Meeting. CB-010, an allogeneic CAR-T cell therapy with partial HLA matching, showed potential to rival currently approved autologous CAR-T therapies in safety an...

Trytosaveabit

Apr 16 05:31

Hmm?

$Caribou Biosciences (CRBU.US)$ Got a inverted hammer on the daily! Its wick actually broke above the downtrend continuation wedge! Its Really OS RSI 7 = 14.58! RSI 14 = 24.96! MACD Looks as if its fixing to GC? So lets just see how this turns out? Just thinking outloud

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

Concept

Gene Editing

Intraday+0.37%

CRBU Caribou Biosciences

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target